Physician profile
Daniel Trif
NPI 1124683552
$5,687.25
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $4,107 · 2024: $1,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,914 · Food and Beverage: $2,007 · Education: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,913.62 |
| Food and Beverage | $2,006.71 |
| Education | $766.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,799.20 | 2023-2024 | Vercise |
| Medtronic, INC. | $1,686.86 | 2023-2024 | Vanta Adaptivestim, Intellis Adaptivestim, Osteocool Rf Ablation System |
| Nevro Corp. | $911.61 | 2023-2024 | Omnia, Senza |
| Abbott Laboratories | $149.49 | 2024 | Eterna |
| Relievant Medsystems, INC. | $40.00 | 2023 | Intracept |
| Spr Therapeutics, INC | $36.30 | 2023 | Sprint Pns System |
| Biotronik Nro, INC. | $24.88 | 2023 | Biotronik |
| Painteq LLC | $24.60 | 2024 | Painteq |
| Saluda Medical Americas, INC. | $14.31 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Trif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.